Latest News

Ipsen (ENXTPA:IPN) has come into focus after presenting fresh preclinical data at the AACR congress for two first in class oncology candidates, IPN01203 and IPN60300, targeting difficult solid tumor indications. See our latest analysis for Ipsen. The latest oncology data and recent conference activity come at a time when Ipsen’s share price has reached €157.7, with recent momentum reflected in a 90 day share price return of 32.97% and a 1 year total shareholder return of 48.68%. This...

If you are wondering whether Archrock's recent share price puts it on sale or already fully priced, it helps to step back and look carefully at what the current valuation actually reflects. At a last close of US$35.52, the stock has returned 0.5% over the past month, 33.4% year to date and 38.7% over the last year. The 3 year and 5 year returns are very large at more than 7x and around 7x respectively, which naturally raises questions about how much future upside or risk is now baked...

Why FirstService is on investors’ radar today FirstService (TSX:FSV) has drawn fresh attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date and over the past year. See our latest analysis for FirstService. The recent 13.2% 1 month share price decline, alongside a 21.1% 1 year total shareholder return decline, suggests momentum has been fading even as the business continues to operate across essential...

WD-40 stock moves after recent share performance WD-40 (WDFC) has drawn fresh attention after recent share performance, with the stock down about 2% over the past day, 6% over the past week, and 16% over the past month. See our latest analysis for WD-40. That recent slide sits against a mixed backdrop, with a 1 year total shareholder return of about 15% decline but a 3 year total shareholder return of roughly 19% gain, so recent momentum looks weaker than the longer term picture. If WD-40’s...

If you are wondering whether Vera Therapeutics at around US$38.86 is priced purely on its story or still leaves some value on the table, this article walks through what the current share price actually implies. The stock has had a mixed run, with a 4.1% decline over the past week and a 4.7% decline over the past month, yet it still shows a 45.9% return over the last year and a very large return over three years. Recent attention on Vera Therapeutics has focused on its position in the biotech...

Earlier this month, Onto Innovation Inc. launched its Dragonfly G5 inspection and metrology system, securing double-digit orders from a high bandwidth memory manufacturer for HBM4 ramp, with shipments scheduled to begin in the second quarter of 2026. The Dragonfly G5’s finer defect sensitivity, higher throughput, and expanded machine learning capabilities highlight how Onto Innovation is deepening its role in advanced semiconductor packaging process control. Next, we’ll explore how the...

WeRide, listed as NasdaqGM:WRD, has launched a share repurchase program covering up to 10% of its issued share capital. In addition, the buyback follows the company’s recent entry into Slovakia to roll out what it calls the country’s first autonomous vehicle initiative. WeRide also presented its next generation Robotaxi at NVIDIA GTC 2026, highlighting its technical partnership and product roadmap. For anyone tracking autonomous driving, WeRide sits at the intersection of software, hardware...

If you are wondering whether Crane NXT is attractively priced or just a value trap, starting with a clear view of its recent share performance and fundamentals can help frame the question. The stock last closed at US$41.15, with a 1.9% gain over the past week, a 14.8% decline over the past month, a 13.8% decline year to date, and a 18.8% decline over the last year. Its 3 year return sits at 9.4%. Recent coverage has focused on providing evergreen context for Crane NXT, aiming to keep...

Wondering whether AllianceBernstein Holding at around US$35.66 is priced attractively, too expensive, or somewhere in between? This article walks through the key signals that matter for you as a shareholder or potential investor. The stock has seen mixed returns, with a 3.9% decline over the past week, a 9.2% decline over the last 30 days, a 7.7% decline year to date, but a 1.0% return over 1 year and gains of 26.7% over 3 years and 31.8% over 5 years. These moves have come as investors...

Alphabet shares after a strong multi year run Alphabet (GOOGL) stock has pulled back recently, with a 2.3% decline over the past day, 8.9% over the week, and about 12% over both the past month and past 3 months. See our latest analysis for Alphabet. Alphabet’s recent pullback has come after a very strong run, with momentum clearly fading in the short term, while the 1 year total shareholder return of 78.38% and 3 year total shareholder return of 166.66% still reflect substantial gains. If...

Wondering whether Southern Copper at around US$162 a share still makes sense for your portfolio, or if the easy gains are already behind it. The stock has returned 6.1% over the last 7 days, while the 30 day return sits at a 25.8% decline and the 1 year return stands at 83.6%, with longer 3 and 5 year returns of 149.7% and 208.1%. Recent market attention has focused on Southern Copper as part of a broader interest in large copper producers and their role in supply for global industry. That...

Wondering whether Nestlé at around CHF 76.37 is priced for quality, or leaving some value on the table for patient shareholders? The stock is up 0.7% over the last week, while the 30 day return is a 9.1% decline and the one year return is a 12.3% decline, which may change how you think about both upside and risk. Recent coverage has focused on Nestlé's position as a global consumer staples giant, its broad portfolio of food and beverage brands, and how that scale influences investor...

Dividend decision at AGM puts Svenska Handelsbanken (OM:SHB A) in focus Svenska Handelsbanken (OM:SHB A) came into focus after shareholders approved a total dividend of SEK 17.50 per share at the 25 March 2026 annual general meeting, combining an ordinary payout and a distribution of remaining profits. See our latest analysis for Svenska Handelsbanken. The dividend decision comes after a weaker recent run in the share price. The 30 day share price return is 17.63% and the year to date share...

Why the brepocitinib data matters for Roivant Sciences (ROIV) The Phase 3 VALOR trial results for brepocitinib in dermatomyositis, published in the New England Journal of Medicine and paired with an FDA Priority Review, put a key Roivant Sciences (ROIV) asset firmly in focus for investors. See our latest analysis for Roivant Sciences. Roivant’s recent brepocitinib milestones arrive after a 1 year total shareholder return of 155.49% and a 3 year total shareholder return of 259.35%. The share...

Home Depot (NYSE:HD) is rolling out new AI tools, including its Magic Apron suite, to reshape how customers and associates interact in stores. The company is deepening its partnership with Google Cloud to link generative AI with both in-store and digital experiences. These updates focus on keeping physical stores relevant as more commerce activity incorporates AI and data driven tools. Home Depot, trading at about $321.65, sits at the center of the home improvement sector with a business...

Lockheed Martin (LMT) is back on many investors’ screens after its recent share price pullback, with the stock down about 6% over the past month but still higher over the past 3 months. See our latest analysis for Lockheed Martin. That pullback sits against a stronger backdrop, with a 90 day share price return of 25.97% and a 1 year total shareholder return of 43.30%. This suggests momentum has cooled recently but remains firm over a longer horizon. If defense exposure is on your radar, this...

Investors wondering if Customers Bancorp at around US$67.66 still offers value, or if most of the easy gains are already behind it, can use this review to frame that question using several valuation lenses. The share price has moved 2.2% over the last week and 0.3% over the last month, with a year to date return of a 9.2% decline, set against a 34.9% gain over the past year, a 3 year return of 265.3%, and a 5 year return of 111.3%. Recent coverage has focused on Customers Bancorp's position...

Client win with Nissay AM puts Triton in focus Nissay Asset Management Corporation has selected Virtu Financial (VIRT) Triton execution management system to handle multi asset trading across global markets after running a comprehensive vendor review against other trading platforms. The decision centers on Triton software capabilities, including support for equities, ETFs, futures, options, FX, and fixed income. It also reflects Nissay AM priorities around workflow efficiency, analytics, and...

CECO and Thermon Group Holdings (NYSE:THR) announced a planned combination that management describes as a scale play with commercial synergies. The transaction is framed around Thermon's 3D strategy of decarbonization, digitalization, and diversification, as well as a shift toward more recurring revenue. Leadership highlights expectations for double-digit growth, improved EBITDA margins, and near term cross selling opportunities across the combined customer base. Thermon, known for...

Home BancShares stock snapshot after recent performance trends Home BancShares (HOMB) has drawn fresh attention after a mixed stretch for the stock, with a roughly 4% decline over the past month and about 6% decline over the past 3 months. At a recent close of US$26.43 and a market value near US$5.2b, the Conway based regional bank sits against a longer record that includes a 3 year total return above 30% and a 5 year total return above 10%. See our latest analysis for Home BancShares. After...

Vulcan Energy Resources (ASX:VUL) has come into focus after releasing its full year 2025 earnings, reporting sales of €7.35 million and a net loss of €69.58 million, along with higher basic and diluted loss per share. See our latest analysis for Vulcan Energy Resources. The earnings release appears to have sharpened attention on risk, with the share price at A$3.27 posting a 3.48% 1 day gain and 9.36% 7 day share price return. However, it is still showing a 12.57% 30 day and 25.68% year to...

Event context and recent share performance Pharvaris (PHVS) shares recently closed at $27.35, with the stock showing mixed short term moves, including a modest 1 day decline and a small pullback over the past month after earlier gains in the past 3 months and year. See our latest analysis for Pharvaris. The recent pullback in Pharvaris’s share price comes after a strong 1 year total shareholder return of 73.10% and a 3 year total shareholder return of 239.54%. However, the 5 year total...

Why Rapport Therapeutics (RAPP) is back on traders' radar Rapport Therapeutics (RAPP) has drawn fresh attention after a recent upgrade to a Zacks Rank #2 (Buy), tied to higher earnings estimates that suggest improving sentiment around the company’s profit outlook. See our latest analysis for Rapport Therapeutics. Despite a recent 1-day share price decline of 4% to US$27.84 and a mixed near-term pattern, Rapport Therapeutics still shows a very strong 1-year total shareholder return of 177.01%,...

Synchrony Financial (SYF) is back in focus after announcing a partnership with Figo Pet Insurance that links Figo policies with CareCredit, aiming to simplify how pet owners pay for and get reimbursed for veterinary care. See our latest analysis for Synchrony Financial. Despite the partnership headlines, the recent 1 month share price return of 5.43% and 3 month share price return of a 22.87% decline suggest fading short term momentum, while the 1 year and 3 year total shareholder returns of...